Aviva plc 2005 Financial statements 136 Financial statements continued Notes to the consolidated financial statements continued 21 Loans a Carrying amounts The carrying amounts of loans at 31 December 2005 and 2004 were as follows: 2005 2004 m m Policy loans 1,020 1,032 Bank loans 125 52 Securitised mortgage loans see note 22 7,476 5,106 Non-securitised mortgage loans 15,224 14,663 Other loans 699 1,202 Total 24,544 22,055 Of the above loans, 12,257 million 2004: 11,014 million is expected to be recovered more than one year after the balance sheet date.
The impairment charge in respect of the above loans, charged to profit for the year, was 8 million 2004: 5 million and reversals of impairments on these loans were 4 million 2004: 4 million.
b Collateral At 31 December 2005, the fair values of collateral which the Group has accepted and is permitted to sell or repledge in the absence of default, and of collateral that the Group has sold and has an obligation to return, were 580 million and nil, respectively 2004: nil and nil, respectively.
22 Securitised mortgages and related assets The Group has loans secured by mortgages, subject to non-recourse finance arrangements, in a UK long-term business subsidiary and in two Dutch subsidiaries.
Details of the relevant transactions are as follows: a United Kingdom In a United Kingdom long-term business subsidiary NUER, the beneficial interest in certain portfolios of lifetime mortgages has been transferred to five special purpose securitisation companies, Equity Release Funding No 1 plc ERF1, Equity Release Funding No 2 plc ERF2, Equity Release Funding No 3 plc ERF3, ERF Trustee No 4 Limited ERF4T held on trust for the benefit of Equity Release Funding No.
4 plc ERF4, and ERF Trustee No 5 Limited ERF5T held on trust for the benefit of Equity Release Funding No.
5 plc ERF5 together the ERF companies, in return for initial consideration and, at later dates, deferred consideration.
The deferred consideration represents receipts accrued within the ERF companies after meeting all their obligations to the note holders, loan providers and other third parties in the priority of payments.
No gain or loss was recognised on the transfers to ERF1, ERF3 and ERF5T, and gains of 5 million and 9 million were recognised on the transfers to ERF2 and ERF4T respectively.
The purchases of the mortgages were funded by the issue of xed rate, oating rate and index-linked notes by the ERF companies.
All the shares in the ERF companies are held by independent companies, whose shares are held on trust.
Although NUER does not own, directly or indirectly, any of the share capital of the ERF companies or their parent companies, these have been treated as subsidiaries in the consolidated financial statements.
NUER has no right to repurchase the benefit of any of the securitised mortgage loans, other than in certain circumstances where NUER is in breach of warranty or loans are substituted in order to effect a further advance.
NUER has purchased subordinated notes and granted subordinated loans to some of the ERF companies.
These have been offset against the borrowings of the ERF companies in the consolidated balance sheet.
b Netherlands In two Dutch subsidiaries, Delta Lloyd Levensverzekering NV DLL and Amstelhuys NV AMS, the principal benets of certain portfolios of mortgage loans have been transferred to a number of special purpose securitisation companies, Arena 2000 - I BV, Arena 2001 - I BV, Arena 2002 - I BV, Arena 2003 - I BV, Arena 2004 - I BV, Arena 2004 - II BV, Arena 2005 - I BV and DARTS Finance BV the securitisation companies, which were funded primarily through the issue of xed rate, oating rate and index-linked notes.
No gains or losses were recognised on these transfers.
